By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



3388 Mike Collins Drive

Eagan  Minnesota  55121  U.S.A.
Phone: 651-675-0300 Fax: 651-675-0400


Biothera Pharmaceuticals, Inc. is advancing Imprime PGG, a unique cancer immunotherapy, through Phase 2 clinical trials in multiple cancer indications. While cancers can actively avoid detection by the immune system, Imprime PGG works like an immunological “ignition switch” to activate a host of anti-tumor immune system responses. These robust, coordinated responses can enhance the therapeutic efficacy of tumor-targeting, anti-angiogenic and immune checkpoint inhibitor antibodies.




CEO: Barry Labinger

CMO: José Iglesias, MD

CSO: Jeremy Graff, PhD

CFO: Steve Karel


Please click here for Biothera job opportunities.


Key Statistics

Ownership: Private

Web Site: Biothera


Company News
Biothera Announces Initiation Of Phase Ib/II Clinical Study Evaluating Combination Of Imprime PGG And Merck & Co. (MRK)’s KEYTRUDA In Non-Small Cell Lung Cancer 7/19/2017 10:36:21 AM
Biothera’s Phase II Study Of Imprime PGG Combination Therapy In Non-Small Cell Lung Cancer Patients Published In Investigational New Drugs 3/27/2017 7:02:02 AM
Biothera Announces Presentation Of Clinical Data Supporting Use Of A Patient Selection Biomarker For Its Phase II Cancer Immunotherapy 2/27/2017 7:42:31 AM
Biothera Announces Data Demonstrating Unique Immune Response Profile Generated By Phase 2 Cancer Immunotherapy Imprime PGG 11/30/2016 12:12:44 PM
Biothera Preclinical Data Further Validate Mechanism Of Its Phase II Cancer Immunotherapy, Imprime PGG 11/11/2016 11:37:29 AM
Clinical Data Support Mechanism Of Action And Patient Selection Biomarker For Imprime PGG, Biothera's Phase II Cancer Immunotherapy 9/27/2016 8:27:34 AM
Biothera Expands Relationship With Merck & Co. (MRK), Enters Collaboration For Combination Cancer Immunotherapy Trials In Multiple Indications 8/24/2016 10:50:14 AM
Biothera To Present At The Canaccord Genuity Growth Conference 8/3/2016 11:10:19 AM
Biothera Presents New Cancer Immunotherapy Research At The 2016 AACR Annual Meeting 4/19/2016 1:07:15 PM
Biothera Announces Presentations at Upcoming AACR Annual Meeting 3/17/2016 11:12:51 AM